Company Biohaven Pharmaceutical Holding Company Ltd.
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.97 USD | +1.12% | -0.05% | -74.33% |
25/04 | Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing | MT |
23/04 | Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO | MT |
Business Summary
Number of employees: 928
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 03/22/03 |
Jon Blaskovich
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 25/17/25 | |
Lisa Stocking
COO | Chief Operating Officer | - | - |
Melissa Beiner
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Gastón Ortega
BRD | Director/Board Member | - | 03/22/03 |
Investor Relations Contact | - | 01/22/01 | |
Marianne Frost
LAW | General Counsel | - | - |
Tamara Noonan
PRN | Corporate Officer/Principal | - | - |
Daniel Franjic
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 03/22/03 |
Gastón Ortega
BRD | Director/Board Member | - | 03/22/03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 107,477,580 | 96,868,157 ( 90.13 %) | 0 | 90.13 % |
Company contact information
Biohaven Pharmaceutical Holding Co. Ltd.
215 Church Street Suite 304
06510-1803, New Haven
+284-852-3000
http://biohavenpharma.com/Sector
1st Jan change | Capi. | |
---|---|---|
-74.33% | 541M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BHVN Stock
- Company Biohaven Pharmaceutical Holding Company Ltd.